IN FOCUSOral dabigatran etexilate vs. subcutaneous enoxaparin for the prevention of venous thromboembolism after total knee replacement: the RE‐MODEL randomized trial
Under an Elsevier user license
open archive
Keywords
dabigatran etexilate
direct thrombin inhibitor
prophylaxis
total knee replacement
venous thromboembolism
Cited by (0)
Copyright © 2007 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc. All rights reserved.